[PDF][PDF] Development of bipotent cardiac/skeletal myogenic progenitors from MESP1+ mesoderm

SSK Chan, HR Hagen, SA Swanson, R Stewart… - Stem cell reports, 2016 - cell.com
SSK Chan, HR Hagen, SA Swanson, R Stewart, KA Boll, J Aho, JA Thomson, M Kyba
Stem cell reports, 2016cell.com
The branchiomeric skeletal muscles co-evolved with new chambers of the heart to enable
predatory feeding in chordates. These co-evolved tissues develop from a common
population in anterior splanchnic mesoderm, referred to as cardiopharyngeal mesoderm
(CPM). The regulation and development of CPM are poorly understood. We describe an
embryonic stem cell-based system in which MESP1 drives a PDGFRA+ population with dual
cardiac and skeletal muscle differentiation potential, and gene expression resembling CPM …
Summary
The branchiomeric skeletal muscles co-evolved with new chambers of the heart to enable predatory feeding in chordates. These co-evolved tissues develop from a common population in anterior splanchnic mesoderm, referred to as cardiopharyngeal mesoderm (CPM). The regulation and development of CPM are poorly understood. We describe an embryonic stem cell-based system in which MESP1 drives a PDGFRA+ population with dual cardiac and skeletal muscle differentiation potential, and gene expression resembling CPM. Using this system, we investigate the regulation of these bipotent progenitors, and find that cardiac specification is governed by an antagonistic TGFβ-BMP axis, while skeletal muscle specification is enhanced by Rho kinase inhibition. We define transcriptional signatures of the first committed CPM-derived cardiac and skeletal myogenic progenitors, and discover surface markers to distinguish cardiac (PODXL+) from the skeletal muscle (CDH4+) CPM derivatives. These tools open an accessible window on this developmentally and evolutionarily important population.
cell.com